Cargando…
CD28-B7 blockade after alloantigenic challenge in vivo inhibits Th1 cytokines but spares Th2
Blocking the CD28-B7 T cell costimulatory pathway with the fusion protein CTLA4Ig inhibits alloimmune responses in vitro and in vivo and induces tolerance to cardiac allografts in mice and rats, but the mechanisms mediating the tolerant state in vivo are unknown. Here, we report the effects and pote...
Formato: | Texto |
---|---|
Lenguaje: | English |
Publicado: |
The Rockefeller University Press
1995
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2192009/ https://www.ncbi.nlm.nih.gov/pubmed/7536798 |
Ejemplares similares
-
CD28 Blockade Ex Vivo Induces Alloantigen-Specific Immune Tolerance but Preserves T-Cell Pathogen Reactivity
por: Dillinger, Barbara, et al.
Publicado: (2017) -
Induction of alloantigen-specific hyporesponsiveness in human T lymphocytes by blocking interaction of CD28 with its natural ligand B7/BB1
Publicado: (1993) -
Cd4(+)Cd25(+) Immune Regulatory Cells Are Required for Induction of Tolerance to Alloantigen via Costimulatory Blockade
por: Taylor, Patricia A., et al.
Publicado: (2001) -
Induction of Alloantigen-specific Anergy in Human Peripheral Blood Mononuclear Cells by Alloantigen Stimulation with Co-stimulatory Signal Blockade
por: Davies, Jeff K., et al.
Publicado: (2011) -
IL-35 inhibits CD8(+) T cells activity by suppressing expression of costimulatory molecule CD28 and Th1 cytokine production
por: Jiang, Hua, et al.
Publicado: (2019)